about
Thrombus formation in vivo.Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophagesLeukocytes and the natural history of deep vein thrombosis: current concepts and future directionsMicrovesicles: mediators of extracellular communication during cancer progressionTissue factor as a proinflammatory agentOvarian cancer, the coagulation pathway, and inflammation"Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus FormationCrossroads of coagulation and innate immunity: the case of deep vein thrombosisMicrofluidics and coagulation biologyComplement-Coagulation Cross-Talk: A Potential Mediator of the Physiological Activation of Complement by Low pHThe role of saliva in tick feedingTissue factor: in at the start...and the finish?Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trialClopidogrel-mediated reduction of circulating tissue factor in patients with stable coronary artery diseaseThrombin and vascular inflammationAcute cardiovascular effects of firefighting and active cooling during rehabilitationTraumatic brain injury-associated coagulopathyComputationally derived points of fragility of a human cascade are consistent with current therapeutic strategiesSpatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively.Caspase-1-mediated pathway promotes generation of thromboinflammatory microparticles.Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets.Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activityIncreased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders.The complex puzzle underlying the pathophysiology of acute coronary syndromes: from molecular basis to clinical manifestations.Blood coagulation, inflammation, and malaria.PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.Potential mechanisms underlying the acute lung dysfunction and bacterial extrapulmonary dissemination during Burkholderia cenocepacia respiratory infection.Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood.Contribution of host-derived tissue factor to tumor neovascularizationExpression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation.Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease.Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes.Does activation of the blood coagulation cascade have a role in malaria pathogenesis?Association study to evaluate TFPI gene in CAD in Han ChinesePlasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexesRole of thrombin signalling in platelets in haemostasis and thrombosis.Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner.The tissue factor requirement in blood coagulation.Ischemia/reperfusion Injury and its Consequences on Immunity and Inflammation.
P2860
Q24536156-CFD622B2-3F4A-4047-BC1C-5A1DBC1C4FFBQ24608957-54627148-96F7-480D-9A5D-F39BD6A242C0Q24611488-7A97A530-29C3-4EA9-9CFD-40BE165BBCF4Q24628728-A458D51E-CA5D-459E-A98D-29E928073E93Q24807263-A2AD5799-C175-4124-B86E-E0E975F52F9FQ24816796-A6728890-6E24-4416-8C8D-59CC00FDD2A0Q26786677-1BD727FA-ACD9-4FB9-994C-4F6E54C7285CQ27003067-C9F0BDD9-3FC3-4DEE-93CA-CECBA51C5DE2Q27026691-DAE8B454-38D3-4B19-9A22-3D5F01B8A689Q27027361-807A6512-1CE9-4BD4-A4D0-F76BFA2CEAF8Q27490448-E5A43596-DA70-4B36-BBEE-2F356284031BQ28188180-723FC0D7-724A-49B1-8977-6A2757E87B6FQ28214135-8837F4F3-4BC5-4542-994E-9A89CADBD663Q28219643-233005EF-B132-4D19-B002-052AF85E0018Q28246124-38A1422C-249F-458B-AF55-E3529353CF51Q28390777-E08BD9C1-B6D9-46D4-9C36-8904387E99A5Q28391580-9FDA578A-27BD-45A3-B31B-8CC38DB56FC8Q28469258-7717722C-B621-41FF-BFF1-82D91344AF48Q30476822-E2032777-EC5B-491F-BC69-2CCAD12F7F21Q30639688-916C14F8-4C75-4CD0-81B2-5A2D15992203Q31117459-C2F26A08-F202-4285-9727-1E1C0577008AQ31144359-7A0C6272-2972-4017-8B04-6387081275C9Q33214236-A095C8C9-5BF5-444C-B8FF-F3CD713F1583Q33348680-9673A9FD-C2BA-4A88-8F31-DB7A94AAB71BQ33354913-F8E539A2-518A-426E-B15E-8F453396F45DQ33378580-9131EB7A-3E4F-4D7E-922C-5C54F8D79D69Q33400120-A7DA0C18-E012-44CE-A689-4C0238495B2BQ33634532-955D5665-AB06-428D-AF3D-D65EFE571F80Q33717037-D668BC83-7154-4C0B-A166-51FC83BC5E2CQ33765271-E60147F5-2F18-4198-8281-370EA2BBA36CQ33867014-25A0BFD4-F0F1-491E-B547-225BFDACEAF2Q33878775-764FAB88-1254-4130-B72F-F9BC9CF870AAQ33900427-BA3184A4-1AD9-42F8-B393-FDDD4EB9C6A5Q33902224-4305DEEB-D8FF-471C-8B59-87BFB8177BABQ33913027-0B42FA84-3BF6-4046-A706-DA650B931A7CQ33941766-FAC88CB1-AC04-41A2-9296-98D2D4350F16Q34090283-CBC6291A-465A-49E9-8ADB-D7491B3BDF99Q34291730-1BE8C628-884D-4C43-A754-A85CAD137E76Q34360277-93025B97-5A70-498E-BB9D-719E625BF8D7Q34532361-C9B53979-A527-4344-8E47-2F7487815179
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Blood-borne tissue factor: another view of thrombosis
@en
Blood-borne tissue factor: another view of thrombosis.
@nl
type
label
Blood-borne tissue factor: another view of thrombosis
@en
Blood-borne tissue factor: another view of thrombosis.
@nl
prefLabel
Blood-borne tissue factor: another view of thrombosis
@en
Blood-borne tissue factor: another view of thrombosis.
@nl
P2093
P2860
P356
P1476
Blood-borne tissue factor: another view of thrombosis
@en
P2093
B Bohrmann
J J Badimon
M A Riederer
P L Giesen
Y Nemerson
P2860
P304
P356
10.1073/PNAS.96.5.2311
P407
P577
1999-03-01T00:00:00Z